Detalhe da pesquisa
1.
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Oncologist
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417095
2.
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer.
Cancer Immunol Immunother
; 73(4): 72, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430405
3.
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
Lancet Oncol
; 24(5): 553-562, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011650
4.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784056
5.
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.
Am J Hematol
; 96(4): 428-435, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421178
6.
Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.
Br J Haematol
; 177(2): 254-262, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28169430
7.
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.
Oncologist
; 22(10): 1152-e98, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765502
8.
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
Oncologist
; 22(10): 1156-e111, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687625
9.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 164(3): 649-658, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28508185
10.
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma.
Haematologica
; 100(5): 670-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710456
11.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
JAMA Oncol
; 9(1): 29-39, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394867
12.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210307
13.
A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.
Cancer Invest
; 29(7): 451-5, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21696296
14.
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.
J Thorac Oncol
; 16(2): 289-298, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33068794
15.
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
; 18(6): 469-476.e4, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641261
16.
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
; 18(6): 461-468.e3, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32718906
17.
OneOncology's Arrowsmith looks forward to real-time dynamics in clinical pathways.
Am J Manag Care
; 28(3 Spec No.): SP102-SP103, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758890
18.
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study.
JCO Oncol Pract
; 17(7): 379-381, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872069
19.
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
Target Oncol
; 11(5): 643-653, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154357
20.
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Leuk Lymphoma
; 44(2): 241-9, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12688340